Article Information
PubMed
Print ISSN
Online ISSN
History
- Received December 8, 2008
- Accepted February 26, 2009
- Published online May 15, 2009.
Article Versions
- Earlier version (February 27, 2009 - 08:21).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Aberra Fura,
- Ashish Khanna1,
- Viral Vyas,
- Barry Koplowitz2,
- Shu-Ying Chang,
- Christian Caporuscio,
- David W. Boulton,
- Lisa J. Christopher,
- Kristina D. Chadwick,
- Lawrence G. Hamann3,
- W. Griffith Humphreys and
- Mark Kirby
- Pharmaceutical Candidate Optimization (A.F., A.K., B.K., S.-Y.C., C.C., L.J.C., W.G.H.), Preclinical and Pharmaceutical Development Informatics (V.V.), Discovery Medicine and Clinical Pharmacology (D.W.B.), Drug Safety Evaluation (K.D.C.), Discovery Chemistry (L.G.H.), and Metabolic Diseases (M.K.), Bristol-Myers Squibb, Research and Development, Princeton, New Jersey
- Address correspondence to:
Dr. Aberra Fura, Department of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Research and Development, MS: LVL F12-02, P.O. Box 4000, Princeton, NJ 08543-4000. E-mail: aberra.fura{at}bms.com